The present invention relates to radiopharmaceuticalcompositions comprising the mother nuclide 224Ra, its daughternuclide 212Pb, and a complexing agent that complexes with the daughternuclide. The use of targeted chelate scavengers for 224Ra daughternuclide opens up the possibility for using 224Ra based solutions formedical treatments.